Whatman Share Discussion Threads

[vanenka] 30/6/2006 20:24

Try out:

Had a few good days with info from there.

[vanenka] 30/6/2006 20:24

Try out:

Had a few good days with info from there.

[go with the flow] 30/6/2006 11:52

Could well top 330p this time!

Flow

[go with the flow] 29/6/2006 14:28

Let's hope so!!!!

[j4ckthehat] 28/6/2006 22:56

Divergene on MACD looks good,getting ready to fly.

[go with the flow] 28/6/2006 14:06

So - a higher low then!

[go with the flow] 27/6/2006 13:11

Well a bounce has developed!!!!

[go with the flow] 15/6/2006 13:37

Is this the higher low developing?

Flow

[go with the flow] 13/6/2006 22:17

Current market conditions are contributing to a pullback.
I would like to see a higher low develop now!

Flow

[j4ckthehat] 08/6/2006 12:59

Holding up very well by the look of the chart,would imagine this will scoot up or flow nicely once market sentiment turns as a whole.
j4

[go with the flow] 06/6/2006 08:31

Well the price has reached 325 again - but - will it hold?

Flow

[go with the flow] 18/5/2006 08:12

The price is holding up well against general market conditions!

I'm confident the price will top 325p soon.

Flow

[go with the flow] 03/5/2006 08:19

Double top or a breakout north?

Well we'll know soon enough!

Flow

[go with the flow] 02/5/2006 12:09

Another good step up this morning!

Flow

[go with the flow] 26/4/2006 19:34

Chart looking strong!

[1a] 20/4/2006 20:11

LONDON (AFX) - Inion Oy, the biodegradable medical implants company, said it
appointed Julien Cotta as chief financial officer from June.
Cotta joins Inion from Whatman PLC, where he was group financial controller.
[e-mail]
ak

what's happening ?

[go with the flow] 13/4/2006 09:15

Hopefully a classic bounce off 305p support level as part of the next leg up!

Flow

[mashman] 05/4/2006 07:53

UBS Ups Whatman To Buy; Sees Growth Delivery

0545 GMT [Dow Jones] UBS upgrades Whatman (WHM.LN) to buy from neutral, lifts the price target to 375p from 320p now the company is "beginning to deliver top line growth." Says the restructuring process post the S&S acquisition is "largely complete," thus expects improving cashflows. Shares closed at 307p. (PBA)

[go with the flow] 04/4/2006 08:36

Resistance broken this morning - let's hope these good results bring more attention to the company.

Flow

[mashman] 04/4/2006 08:28

The Investment Column: Thian's turnaround makes Whatman a hold.


Edited by Michael Jivkov
Published: 04 April 2006
Nearly 250 years ago, Whatman was busy making drawing paper for the likes of Turner and Constable. Since then the group has been through its fair share of ups and downs, and today is focused on producing filters, throwaway blotters and membranes used in laboratory and factor tests.

If readers had bought into Whatman three years ago they would be sitting on a 350 per cent capital gain. Over this period, under the chairmanship of Bob Thian, the group has achieved a impressive turnaround, going from the red to an annual pre-tax profit of £21m, unveiled yesterday. Cost savings and efficiency gains have been behind this. For example, when Mr Thian took over, Whatman operated out of 21 sites across the globe. Today this figure stands at just four. It has rationalised its product range from 16,000 lines to a more manageable 4,000.

The purchase in 2004 of the German rival Schleicher & Schuell gave its profit line an added boost. It has produced synergies far greater than anyone in the City had expected. And there could well be more such deals in the future. The group certainly has the firepower, while there are plenty of targets for it to go after, given how fragmented its industry is outside the top three players.

Now the focus is on Whatman's ability to grow its top line. If the first-quarter sales figures it posted yesterday are anything to go by, it should have little trouble. The group had promised to deliver a rise in revenues of 6-8 per cent for 2006. For the quarter just passed it unveiled 11 per cent growth and a strong order book.

The story so far makes Whatman shares clearly worth holding on to, despite their strong run. The fact that the company is the only one in the world which has the technology to store DNA at room temperature makes the stock a buy. Whatman's innovation does away with the need for the cumbersome and expensive fridges currently required and opens the door to what is likely to be a very lucrative market for the company. So far it is already being used by the French police, the FBI and the CIA.

IFX Group

The recovery at IFX Group, enacted by its chief executive Edmond Warner, is finally bearing fruit. Yesterday, the foreign exchange trading and spread-betting firm said its profits for the year ending 31 March would come in at £3.4m, more than the £3.1m forecast by analysts. This performance represents a near doubling on the profits achieved by IFX in 2005.

Since Mr Warner took over in 2003 he has focused it on providing equity products, through Finspreads, and on foreign exchange. More recently he has opened an office in Shanghai offering spread-betting. Given the Chinese love of gambling, the potential market is huge.

Spread betting allows investors to take positions in the stock or foreign exchange markets. It enables punters to gear up their bets - that is, cash in on movements in valuations with only a small outlay of capital - and avoid paying tax on any profits they may make. The recent boom in the UK stock market has been particularly good news for Finspreads.

The IFX boss believes his work is now done and plans to quit this year. He will leave it with £19.5m of cash on its balance sheet, up from £16.8m last year, which accounts for about half the group's market capitalisation. Strip this out and the shares trade at just nine times forecast earnings for this year. This is a significant discount to the rating enjoyed by the quoted rivals IG Group and London Capital, which is unwarranted. Buy.

Nearly 250 years ago, Whatman was busy making drawing paper for the likes of Turner and Constable. Since then the group has been through its fair share of ups and downs, and today is focused on producing filters, throwaway blotters and membranes used in laboratory and factor tests.

If readers had bought into Whatman three years ago they would be sitting on a 350 per cent capital gain. Over this period, under the chairmanship of Bob Thian, the group has achieved a impressive turnaround, going from the red to an annual pre-tax profit of £21m, unveiled yesterday. Cost savings and efficiency gains have been behind this. For example, when Mr Thian took over, Whatman operated out of 21 sites across the globe. Today this figure stands at just four. It has rationalised its product range from 16,000 lines to a more manageable 4,000.

The purchase in 2004 of the German rival Schleicher & Schuell gave its profit line an added boost. It has produced synergies far greater than anyone in the City had expected. And there could well be more such deals in the future. The group certainly has the firepower, while there are plenty of targets for it to go after, given how fragmented its industry is outside the top three players.

Now the focus is on Whatman's ability to grow its top line. If the first-quarter sales figures it posted yesterday are anything to go by, it should have little trouble. The group had promised to deliver a rise in revenues of 6-8 per cent for 2006. For the quarter just passed it unveiled 11 per cent growth and a strong order book.

The story so far makes Whatman shares clearly worth holding on to, despite their strong run. The fact that the company is the only one in the world which has the technology to store DNA at room temperature makes the stock a buy. Whatman's innovation does away with the need for the cumbersome and expensive fridges currently required and opens the door to what is likely to be a very lucrative market for the company. So far it is already being used by the French police, the FBI and the CIA

[go with the flow] 03/4/2006 09:02

If it can break & sustain 308p then the next resistance point is 350ish!

Flow

[go with the flow] 03/4/2006 08:13

LONDON (ShareCast) - Chemical products maker Whatman (LSE: WHM.L - news) said a solid rise in full year earnings, boosted by a recovery in sales in second half of year.
Pre-tax profit rose to £21.2m for the year ended 31 December 2005 from £0.5m the year before on sales which increased to £110m from £76.4m. The total dividend increased by 10% to 5.07p per share.
Whatman said the current year had started well, with first quarter sales up 11%
'Despite disappointing sales growth in 2005, we have seen substantial growth in profits and earnings at Whatman, driven primarily by the higher than expected synergies from the acquisition of Schleicher & Schuell in Germany," said chairman Bob Thian.
The group also said it had completed key executive appointments, including chief executive Bill Emhiser, former president of the North American operations of Proteome.

Positive start to the week!

Flow

[go with the flow] 28/3/2006 19:15

Good move back north!

Flow

[go with the flow] 24/3/2006 10:44

The 2 year graph indicates that the WHM share price is quite volatile with recent intraday movements of 5+% being the norm.

In view of this I may alter my strategy & deal on a shorter time frame rather than remain a long term holder. However, the spread is typically wide allowing good margins for our MM friends but makes it less advantageous for the smaller investor.

I want to see a further bounce from here!

Flow